Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Helius Medical Technologies, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
42328V801
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2023
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------------------------------------------------------------------
CUSIP No. 42328V801 13G Page 2 of 5 Pages
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Columbus Capital Management, LLC
94-3262667
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group
(See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
California, USA
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
50,000 shares of Common Stock and 20,116 warrants to
purchase shares of Common Stock. (See Item 4)
-------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -------------------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 50,000 shares of Common Stock and 20,116 warrants to
purchase shares of Common Stock. (See Item 4)
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
50,000 shares of Common Stock and 20,116 warrants to purchase shares
of Common Stock. (See Item 4)
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) |_|
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
9.90%
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IA
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 42328V801 13G Page 3 of 5 Pages
Item 1.
(a) Name of Issuer:
Helius Medical Technologies, Inc.
(b) Address of Issuer's Principal Executive Offices:
642 Newtown Yardley Road, Suite 100, Newtown, PA 18940
Item 2.
(a) Name of Person Filing:
Columbus Capital Management, LLC
(b) Address of the Principal Office or, if none, residence:
301 E. Strawberry Drive, Mill Valley, CA 94941
(c) Citizenship:
California, USA
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
42328V801
Item 3. If this statement is filed pursuant to SS.240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a) |_| Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) |_| Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8).
(e) | | An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with
S.240.13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with
S. 240.13d-1(b)(1)(ii)(G);
(h) |_| A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
(j) |_| Group, in accordance with S.240.13d-1(b)(1)(ii)(J).
--------------------------------------------------------------------------------
CUSIP No. 42328V801 13G Page 4 of 5 Pages
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 50,000 shares of Common Stock and 20,116
warrants to purchase shares of Common Stock.
(b) Percent of class: 9.90%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 50,000 shares of
Common Stock and 20,116 warrants to purchase shares of Common
Stock.
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of:
50,000 shares of Common Stock and 20,116 warrants to purchase
shares of Common Stock.
Pursuant to the terms of the reported warrants, the Reporting Person
cannot exercise any of the warrants if the Reporting Person would
beneficially own, after such exercise, more than 9.90% of the
outstanding shares of Common Stock ("the 9.90% Blocker"). Consequently,
at this time, the Reporting Person is not able to exercise all warrants
due to the 9.90% Blocker. The percentage set forth in Row (11) of
the cover page for the Reporting Person gives effect to the 9.90%
Blocker.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following |_|.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
--------------------------------------------------------------------------------
CUSIP No. 42328V801 13G Page 5 of 5 Pages
Item 10. Certification
(a) The following certification shall be included if the statement is
filed pursuant to S.240.13d-1(b):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having that purpose or effect
(b) The following certification shall be included if the statement is
filed pursuant to S.240.13d-1(c):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
02/13/2024
-------------------------------------------
Date
/s/ David S. Proskin
-------------------------------------------
Signature
David S. Proskin, Chief Financial Officer
-------------------------------------------
Name/Title